Aspirin Significantly Reduces the Severity of the Individual Symptoms of Flushing Associated With Niacin Extended-Release Therapy

被引：0

作者：

Lewin, Andrew ^{[1
]}

Kashyap, Moti ^{[2
]}

Jiang, Ping ^{[3
]}

Everhart, Wendy ^{[3
]}

Thakker, Kamlesh ^{[3
]}

机构：

[1] Natl Res Inst, Los Angeles, CA USA

[2] Univ Calif Irvine, Long Beach VA Med Ctr, Irvine, CA USA

[3] Abbott Labs, Abbott Pk, IL 60064 USA

来源：

JOURNAL OF CARDIOVASCULAR NURSING | 2012年 / 27卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：373 / 373

页数：1

共 50 条

[31] Efficacy of venlafaxine extended-release compared with placebo in major depressive disorder patients by severity of anxiety symptoms
Lyndon, G.
Prieto, R.
Wajsbrot, D.
Allgulander, C.
Bandelow, B.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S807 - S808
[32] Modeled achievement of optimal lipid values and associated cardiovascular event rates with extended-release niacin/simvastatin, ezetimibe/simvastatin, and individual agents in a managed care population
Charland, S. L.
Quimbo, R.
Cziraky, M. J.
Weathermon, R. A.
Stanek, E. J.
VALUE IN HEALTH, 2007, 10 (03) : A56 - A56
[33] Is combination therapy with aspirin and extended-release dipyridamole more effective than clopidogrel for preventing recurrent stroke?
Jesse Weinberger
Current Cardiology Reports, 2009, 11 (1) : 3 - 3
[34] Modeled achievement of optimal lipid targets with extended-release niacin/lovastatin versus simvastatin/ezetimibe combination therapy in women
Stanek, EJ
Quimbo, R
Cziraky, MJ
Charland, SL
CIRCULATION, 2006, 113 (08) : E365 - E365
[35] Once-daily niacin extended-release/lovastatin combination is effective and safe for treatment of dyslipidemia associated with metabolic syndrome
McGovern, ME
Malott, CM
Simmons, PD
Stanek, EJ
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 486A - 487A
[36] Extended-Release Niacin Reduces LDL-C Particle Number Even In The Absence Of Changes In Total LDL-C Levels
Jafri, Haseeb
Kuvin, Jeffrey T.
Alsheikh-Ali, Alawi A.
Mooney, Paula
Kimmelstiel, Carey D.
Karas, Richard H.
CIRCULATION, 2008, 118 (18) : S1150 - S1150
[37] The efficacy of levomilnacipran extended-release (ER) in the treatment of patients with depression-associated fatigue symptoms
Fava, M.
Gommoll, C.
Chen, C.
Greenberg, W. M.
Ruth, A.
D'Souza, I.
Terner-Rosenthal, J.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S456 - S457
[38] Reduction in cardiovascular events and associated cost after treatment initiation with niacin extended-release plus simvastatin combination therapy versus simvastatin plus ezetimibe fixed dose therapy
Simko, R.
Quimbo, R.
Cziraky, M. J.
Balu, S.
EUROPEAN HEART JOURNAL, 2009, 30 : 368 - 368
[39] Ropinirolle CR - A new extended-release formulation - Reduces symptom severity in patients with primary restless legs syndrome (RLS)
Ferguson, James M.
Becker, Philip
Williams, Nicola J.
NEUROLOGY, 2007, 68 (12) : A255 - A256
[40] Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)
McKenney, James M.
Jones, Peter H.
Bays, Harold E.
Knopp, Robert H.
Kashyap, Moti L.
Ruoff, Gary E.
McGovern, Mark E.
ATHEROSCLEROSIS, 2007, 192 (02) : 432 - 437

← 1 2 3 4 5 →